Skip to main content

Ganymede Bio and Kytopen to bring cloud-native structured data to gene-modified cell therapy

Laboratory automation, biotechnology

Credit: motorolka/Shutterstock

Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, and Kytopen, a leader in the development and commercialisation of non-viral transfection tools for genome engineering, today announced a partnership to bring the power of cloud native, structured data to Kytopen’s Flowfect platforms. Under this collaboration, the Kytopen transfection systems will integrate Ganymede’s Lab-as-Code platform for:

Welcome to Scientific Computing World

Already registered?  Sign in to continue reading

Not got an account?  Register for free to continue reading

Media Partners